Abstract
SATB2-associated syndrome (SAS) is a rare disorder caused by alterations in the special AT-rich sequence-binding protein 2 (SATB2). Skeletal abnormalities such as tibial bowing, osteomalacia, osteopenia or osteoporosis have been reported suggesting a higher frequency of skeletal complications in SAS. The optimal timing, necessity, and methodology for routine assessment of bone health in individuals with SAS, however, remain unclear. We report molecular and phenotypic features of 7 individuals with SAS documented to have low bone mineral density (BMD) ascertained by dual-energy X-ray absorptiometry (DXA), often preceded by tibial bowing. The lowest BMD Z-scores ranged −2.3 to −5.6. In 4 individuals, total alkaline phosphatase levels were elevated (2 with elevated bone fraction) around the time of low BMD documentation. A clinically significant fracture history and a diagnosis of pediatric osteoporosis were present in 4 individuals. Pamidronate treatment in 2 children improved BMD. In conclusion, low BMD, fractures, and tibial bowing are relatively common skeletal complications in individuals with SAS. DXA is a useful tool when evaluating a child with SAS suspected to have low BMD and the results might alter clinical management.
| Original language | English |
|---|---|
| Pages (from-to) | 588-594 |
| Number of pages | 7 |
| Journal | Clinical Genetics |
| Volume | 93 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 2018 |
Bibliographical note
Publisher Copyright:© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Funding
We thank the families involved in this study for their generous collaboration as well as Dr Colin J. Ross and Dr B. Drogemoller for Sanger analysis of individual 7. This work was supported by funding from the BCCH Foundation as “1st Collaborative Area of Innovation” (www. tidebc.org) and the Canadian Institutes for Health Research (#301221 grant). Informatics infrastructure was supported by Genome BC and Genome Canada (ABC4DE Project). CDvK is recipient of the Michael Smith Foundation for Health Research Scholar Award. AMM is funded through a BCCH Research Institute fellowship. BCCH Foundation as ‘‘1st Collaborative Area of Innovation’’ (www.tidebc.org); Canadian Institutes for Health Research (#301221 grant); Genome BC and Genome Canada (ABC4DE Project); Michael Smith Foundation for Health Research Scholar Award; BCCH Research Institute fellowship. We thank the families involved in this study for their generous collaboration as well as Dr Colin J. Ross and Dr B. Drogemoller for Sanger analysis of individual 7. This work was supported by funding from the BCCH Foundation as ?1st Collaborative Area of Innovation? (www.tidebc.org) and the Canadian Institutes for Health Research (#301221 grant). Informatics infrastructure was supported by Genome BC and Genome Canada (ABC4DE Project). CDvK is recipient of the Michael Smith Foundation for Health Research Scholar Award. AMM is funded through a BCCH Research Institute fellowship. All authors have no conflicts of interest to declare.
| Funders | Funder number |
|---|---|
| Genome Canada | |
| Michael Smith Foundation for Health Research | |
| BCCH Research Institute | |
| BCCH Foundation | |
| Genome British Columbia | |
| CHEO Research Institute | |
| Canadian Institutes of Health Research | 301221 |
Keywords
- Pamidronate
- SATB2
- bone density
- osteopenia
ASJC Scopus subject areas
- Genetics
- Genetics(clinical)
Fingerprint
Dive into the research topics of 'Bone health and SATB2-associated syndrome'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver